As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer ...

Galderma (SIX: GALD) will present data on its innovative and industry-leading neuromodulator portfolio at the TOXINS 2026 International Conference in Madrid, Spain from January 14-17, 2026. The ...

TIESA will use Open-LIFU in AI-guided, noninvasive research on neuromodulation for mental health conditions. SAN ...

Valencia’s eCoin implantable tibial nerve stimulation (ITNS) system for urge urinary incontinence (UUI) treatment gained FDA ...

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical research collaboration to evaluate precision radiomodulation therapy for ...

The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...

Spiro Medical announced today that it closed a $67 million Series A equity financing to support its neuromodulation system.

Saluda Medical, Inc. (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing ...

GrayMatters Health (GMH), the pioneers of digital brain-region biomarkers for mental healthcare, today announced the publication of new clinical and scientific research that significantly broadens the ...

Kaneka Medical America LLC, a subsidiary company of Kaneka Corporation, innovating embolization coil technology for neurovascular therapies, today announced the U.S. launch of the WaveSelect TM 1014 ...

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies ...